Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed May 19, 2025
- Accession no.
- 0001773751-25-000165
- Filed
- May 19, 2025
- Trade date
- May 16, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.3M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | Class A Common Stock | SSaleDisposed | −2,792 | $59.27F2 | −$165,481.84 | 89,311 | Direct | |
| May 16, 2025 | Class A Common Stock | SSaleDisposed | −25,307 | $57.86F3 | −$1,464,263.02 | 307,421 | Indirect | |
| May 16, 2025 | Class A Common Stock | SSaleDisposed | −22,227 | $58.70F4 | −$1,304,724.9 | 285,194 | Indirect | |
| May 16, 2025 | Class A Common Stock | MOption exerciseAcquired | +17,001 | $2.43 | +$41,312.43 | 106,312 | Direct | |
| May 16, 2025 | Class A Common Stock | SSaleDisposed | −17,001 | $58.72F5 | −$998,298.72 | 89,311 | Direct | |
| May 16, 2025 | Class A Common Stock | MOption exerciseAcquired | +108,334 | $2.43 | +$263,251.62 | 197,645 | Direct | |
| May 16, 2025 | Class A Common Stock | SSaleDisposed | −49,265 | $57.84F6 | −$2,849,487.6 | 148,380 | Direct | |
| May 16, 2025 | Class A Common Stock | SSaleDisposed | −52,642 | $58.67F7 | −$3,088,506.14 | 95,738 | Direct | |
| May 16, 2025 | Class A Common Stock | SSaleDisposed | −6,427 | $59.21F8 | −$380,542.67 | 89,311 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | Class A Common Stock | MOption exerciseDisposed | −17,001 | $0.00 | $0 | 102,010 | Direct | |
| May 16, 2025 | Class A Common Stock | MOption exerciseDisposed | −108,334 | $0.00 | $0 | 973,065 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.00 - $59.455. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.43 - $58.38. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.50 - $59.16. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.50 - $59.19. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.42 - $58.405. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.42 - $58.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.00 - $59.525. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.